Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO.
van Kooten JP, Dietz MV, Guchelaar NAD, Brandt-Kerkhof ARM, Koolen SLW, Burger JWA, Mathijssen RHJ, Verhoef C, Aerts JGJV, Madsen EVE. van Kooten JP, et al. Among authors: dietz mv. BMJ Open. 2022 Jun 22;12(6):e062907. doi: 10.1136/bmjopen-2022-062907. BMJ Open. 2022. PMID: 35732399 Free PMC article. Clinical Trial.
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.
Dietz MV, Quintelier KLA, van Kooten JP, de Boer NL, Vink M, Brandt-Kerkhof ARM, Verhoef C, Saeys Y, Aerts JGJV, Willemsen M, Van Gassen S, Madsen EVE. Dietz MV, et al. J Immunother Cancer. 2023 Aug;11(8):e007070. doi: 10.1136/jitc-2023-007070. J Immunother Cancer. 2023. PMID: 37536940 Free PMC article. Clinical Trial.
Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
Dietz MV, van Kooten JP, Said I, Brandt-Kerkhof ARM, Verhoef C, Bremers AJA, de Wilt JHW, de Reuver PR, Madsen EVE. Dietz MV, et al. Ann Surg Oncol. 2022 Oct;29(11):6566-6576. doi: 10.1245/s10434-022-11805-9. Epub 2022 May 5. Ann Surg Oncol. 2022. PMID: 35513588 Free PMC article.
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
Dietz MV, Ziekman MJ, van Kooten JP, Brandt-Kerkhof ARM, van Meerten E, Verhoef C, Madsen EVE. Dietz MV, et al. Ann Surg Oncol. 2023 Apr;30(4):2048-2056. doi: 10.1245/s10434-022-12969-0. Epub 2022 Dec 24. Ann Surg Oncol. 2023. PMID: 36566258
[No title available]
[No authors listed] [No authors listed] PMID: 36719571
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
van Eerden RAG, de Boer NL, van Kooten JP, Bakkers C, Dietz MV, Creemers GM, Buijs SM, Bax R, de Man FM, Lurvink RJ, Diepeveen M, Brandt-Kerkhof ARM, van Meerten E, Koolen SLW, de Hingh IHJT, Verhoef C, Mathijssen RHJ, Burger JWA. van Eerden RAG, et al. Among authors: dietz mv. Br J Surg. 2023 Oct 10;110(11):1502-1510. doi: 10.1093/bjs/znad228. Br J Surg. 2023. PMID: 37467389 Clinical Trial.
11 results